The Multiple Sclerosis and Autoimmune Neurology Update 2027 is organized by the Mayo Clinic School of Continuous Professional Development and is scheduled to take place from February 1 to February 4, 2027, at The Westin Hapuna Beach Resort in Waimea, Hawaii. This activity is offered in a hybrid format, accommodating both in-person attendees and virtual livestream participants.
Course directors B. Mark Keegan, M.D., Eoin Flanagan, M.B., B.Ch., Samantha Banks, M.D., and Sarosh Irani, B.M., B.Ch., D.Phil., have structured a four-day educational initiative delivering evidence-based, practical, and multidisciplinary care strategies in demyelinating and autoimmune neurological disorders. Topics encompass the 2024 revised diagnostic criteria for multiple sclerosis, radiologically isolated syndrome (RIS), tumefactive MS forms, progressive disease, optic neuritis, pediatric MS, and management of disease-modifying therapy side effects. It also covers myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), aquaporin-4-IgG positive neuromyelitis optica spectrum disorders (NMOSD), neurosarcoidosis, neuro-ophthalmology, treatment-responsive rapidly progressive dementia, neural antibody testing, autoimmune movement disorders, and neuro-oncology complications involving CAR T-cell therapy and immune checkpoint inhibitors.
The target audience includes physicians, nurses, nurse practitioners, physician assistants, allied health professionals, residents, fellows, pharmacists, physical and occupational therapists, healthcare executives, and social workers. Each morning begins with an optional Meet the Course Director Workshop covering challenging clinical case discussions.
Continuing medical education accreditation is provided by the Mayo Clinic College of Medicine and Science, which designates the live activity for a maximum of 17.00 AMA PRA Category 1 Credits ™. Other available accreditations include 17.00 AAPA Category 1 CME credits, up to 17.00 ACHE Qualifying Education Hours, a maximum of 3.5 ACPE knowledge-based contact hours, 17.00 ANCC contact hours, and 17.00 Interprofessional Continuing Education (IPCE) credits.
Registration fees are tiered based on professional role: $1195 for M.D., D.O., and Ph.D. attendees, and $975 for Allied Health professionals, NPs, PAs, and Retirees. Original research abstracts relating to multiple sclerosis and autoimmune neurology were accepted through the submission deadline of Friday, September 4, 2026, leading up to an on-site poster session.
Fees (as published by the organiser): M.D., D.O., Ph.D.: $1195; Allied Health, NP, PA, Retirees: $975
Credits: Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 17.00 AMA PRA Category 1 Credits ™.
Faculty / directors: B. Mark Keegan, M.D., Mayo Clinic; Eoin Flanagan, M.B., B.Ch., Mayo Clinic; Samantha Banks, M.D., Mayo Clinic; Sarosh Irani, B.M., B.Ch., D.Phil., Mayo Clinic; Orhun Kantarci, M.D.; Oliver Tobin, M.B., B.Ch., B.A.O., Ph.D.; Mischa Pless, M.D.; Jan-Mendelt Tillema, M.D.; Dean Wingerchuk, M.D.; Stephanie Syc-Mazurek, M.D., Ph.D.; Neeraj Kumar, M.D.; Allen Aksamit JR, M.D.; Deena Tajfirouz, M.D.; Eric Eggenberger, D.O.; Jonathan Carter, M.D.
Sponsors / partners: Alexion AstraZeneca Rare Disease, Genentech
Abstract submissions closed on 2026-09-04.